PhaseBio Pharmaceuticals Inc. (PHAS) tumbled -5.02% or -0.16 to $3.03. It is near 16982 shares traded, which is 56.29% compare to the average total volume 30167. The market cap of PHAS is $74.23 million. The year to date change is -3.26%. The 52 week price range is from $2.55 to $6.0. Price of PHAS have changed -10.14% during last week. It have changed -9.12% over last month, -37.33% over last 3 months, -36.20% over last 6 months and -36.20% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PHAS is 3.43. It is 13.20% above current price. The 52-week High is 6.0. It is 98.02% from the current price. The 52-week Low is 2.55. It is -15.84% from current price.
There are some statistics of PHAS. It is has market cap $74.23 million. The share outstanding is 24.50 million. The average volume is 30167. The percent of top 15 Institution holding is 4.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PHAS is 17.05%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PHAS is -72.08%.